← Open Payments lookup

LISA WYDRA: Open Payments

NPI 1780916916 · HAZLET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$761 in 44 payments from 16 companies in 2025. Trend: 2023 $71 · 2024 $779 · 2025 $761

Food & beverage: $741Consulting: $20
CompanyPaymentsAmount
GlaxoSmithKline, LLC.13$198
Novartis Pharmaceuticals Corporation4$76
CSL Behring3$58
Amgen Inc.3$52
Genentech USA, Inc.3$51
AstraZeneca Pharmaceuticals LP3$50
GENZYME CORPORATION2$48
ARS Pharmaceuticals Operations, Inc.3$45
Takeda Pharmaceuticals U.S.A., Inc.2$43
Regeneron Healthcare Solutions, Inc.2$34

Products named: TRELEGY ELLIPTA, DUPIXENT, TEZSPIRE, Xolair, FASENRA, NEFFY, NUCALA, Hizentra.

Industry payments across NJ — which companies pay providers there.